TD Cowen lifted its price objective on shares of Iovance Biotherapeutics.
3 reports, 1 independent
Updated Nov 6
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen lifted its price objective on shares of Iovance Biotherapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Iovance Biotherapeutics
American biopharmaceutical startup
Nothing else this week.
Related events
- TD Cowen lowered its price target for Ceva shares on November 2, 2026.
- TD Cowen lowered its price target for Beauty Health, while Invesco and Rhumbline increased their holdings in the stock.
- TD Cowen boosted its price objective on Corebridge Financial.
- TD Cowen boosted its price target and gave a buy rating for Jazz Pharmaceuticals.
- TD Cowen issued research notes on GE Vernova stock on July 1, 2026.